PureTech Health PLC
LSE:PRTC
PureTech Health PLC
Revenue
PureTech Health PLC
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
PureTech Health PLC
LSE:PRTC
|
Revenue
$15.6m
|
CAGR 3-Years
17%
|
CAGR 5-Years
44%
|
CAGR 10-Years
N/A
|
|
Abbvie Inc
NYSE:ABBV
|
Revenue
$54.3B
|
CAGR 3-Years
6%
|
CAGR 5-Years
11%
|
CAGR 10-Years
11%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Revenue
$27.5B
|
CAGR 3-Years
2%
|
CAGR 5-Years
4%
|
CAGR 10-Years
7%
|
|
Amgen Inc
NASDAQ:AMGN
|
Revenue
$28.2B
|
CAGR 3-Years
4%
|
CAGR 5-Years
3%
|
CAGR 10-Years
4%
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Revenue
$9.9B
|
CAGR 3-Years
17%
|
CAGR 5-Years
26%
|
CAGR 10-Years
23%
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Revenue
$13.1B
|
CAGR 3-Years
16%
|
CAGR 5-Years
14%
|
CAGR 10-Years
20%
|
See Also
What is PureTech Health PLC's Revenue?
Revenue
15.6m
USD
Based on the financial report for Dec 31, 2022, PureTech Health PLC's Revenue amounts to 15.6m USD.
What is PureTech Health PLC's Revenue growth rate?
Revenue CAGR 5Y
44%
Over the last year, the Revenue growth was -10%. The average annual Revenue growth rates for PureTech Health PLC have been 17% over the past three years , 44% over the past five years .